Dr. Asbell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2 Cooper Plz
Camden, NJ 08103Phone+1 855-632-2667Fax+1 856-735-6467
Summary
- Dr. Sucha Asbell is a radiation oncologist in Merion Station, PA and is affiliated with multiple hospitals in the area, including Cooper University Health Care, Holy Redeemer Hospital, Lankenau Medical Center, and Abington Hospital. She received her medical degree from Medical College of Pennsylvania and has been in practice 51 years. She specializes in breast cancer, gynecologic cancer, and thoracic cancer.
Education & Training
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Radiation Oncology, 1967 - 1971
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHInternship, Internal Medicine, 1966 - 1967
- MCP-Hahnemann College of MedicineClass of 1966
Certifications & Licensure
- FL State Medical License 2006 - 2026
- NJ State Medical License 2006 - 2025
- NY State Medical License 2006 - 2025
- PA State Medical License 1967 - 2024
- DE State Medical License 2006 - 2023
- American Board of Radiology Therapeutic Radiology
Awards, Honors, & Recognition
- gold medal acro, 2020
Clinical Trials
- Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
Publications & Presentations
PubMed
- 1224 citationsChemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group.Jay S. Cooper, Matthew D. Guo, Arnold Herskovic, John S. Macdonald, James A. Martenson
JAMA. 1999-05-05 - 50 citationsThe impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable non-small cell lung cancer: an analysis of RTOG data.Bahman Emami, Nena Mirkovic, Charles Scott, Roger W. Byhardt, Mary V. Graham
Lung Cancer. 2003-08-01 - 164 citationsInterruptions of high-dose radiation therapy decrease longterm survival of favorable patients with unresectable nonsmall cell carcinoma of the lung: analysis of 1244 c...James D. Cox, Thomas F. Pajak, Sucha O. Asbell, Anthony H. Russell, John Pederson
International Journal of Radiation Oncology, Biology, Physics. 1993-10-20
Press Mentions
- Jacksonville, Florida GenesisCare Medical Director Installed as President of American College of Radiation OncologyFebruary 23rd, 2021
Grant Support
- Clinical Studies In Radiation OncologyNational Cancer Institute1985–1989
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: